跳至主要内容
临床试验/IRCT201412097677N3
IRCT201412097677N3已完成2 期

Comparative study of the efficacy of combination and single therapy of exjade and desferal on ferritin level in patients with major thalassemia

Vice chancellor for research, Kermanshah University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 14 years(—)
性别
All

入选标准

  • Inclusion Criteria: Approved based on clinical symptoms and history of thalassemia and hemoglobin electrophoresis; full cooperation during the study; treatment with deferoxamine subcutaneous injection and ferritin levels below 3000. Exclusion criteria: Deferiprone gastrointestinal intolerance; leukocytes less than 3,000; severe liver disease; ascites; lack of consent, lack of cooperation in the history of previous treatment regimens (blood transfusion and deferoxamine).

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Kermanshah University of Medical Sciences

相似试验